These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3595375)

  • 1. Cutaneous delayed hypersensitivity in Crohn's disease and ulcerative colitis. Application of multi-test.
    Triantafillidis JK; Economidou J; Manousos ON; Efthymiou P
    Dis Colon Rectum; 1987 Jul; 30(7):536-9. PubMed ID: 3595375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis.
    Meyers S; Sacher DB; Taub RN; Janowitz HD
    Gut; 1976 Nov; 17(11):911-5. PubMed ID: 1087263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular hypersensitivity to components of intestinal mucosa in ulcerative colitis and Crohn's disease.
    Bendixen G
    Gut; 1969 Aug; 10(8):631-6. PubMed ID: 5810973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of immune reactions in the pathogenesis of ulcerative colitis and Crohn's disease].
    Mackiewicz S
    Przegl Lek; 1973; 30(10):838-40. PubMed ID: 4770505
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies.
    Meyers S; Sachar DB; Taub RN; Janowitz HD
    Gut; 1978 Apr; 19(4):249-52. PubMed ID: 648933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity.
    Lyanga J; Davis P; Thomson AB
    West J Med; 1988 Apr; 148(4):421-5. PubMed ID: 3388844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte migration test in Crohn's disease, ulcerative colitis, and ankylosing spondylitis using Crohn's colon homogenate, mitochondrial, and microsomal fractions.
    Williams MJ; Richens ER; Gough KR; Ancill RJ
    Am J Dig Dis; 1975 May; 20(5):425-9. PubMed ID: 1130367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin test reactivity in inflammatory bowel disease in the United States and Czechoslovakia.
    Thayer WR; Fixa B; Komarkova O; Charland C; Field CE
    Am J Dig Dis; 1978 Apr; 23(4):337-40. PubMed ID: 665629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atopy in inflammatory bowel disease.
    Mee AS; Brown D; Jewell DP
    Scand J Gastroenterol; 1979; 14(6):743-6. PubMed ID: 531506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological studies in inflammatory bowel disease.
    Pepys MB; Druguet M; Klass HJ; Dash AC; Mirjah DD; Petrie A
    Ciba Found Symp; 1977 Apr 26-28; (46):283-304. PubMed ID: 346325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.
    Kusugami K; Youngman KR; West GA; Fiocchi C
    Gastroenterology; 1989 Jul; 97(1):1-9. PubMed ID: 2785943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of exudative neutrophilic granulocytes in patients with Crohn's disease or ulcerative colitis.
    Wandall JH
    Scand J Gastroenterol; 1985 Nov; 20(9):1151-6. PubMed ID: 4089525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature.
    Annese V; Piepoli A; Latiano A; Lombardi G; Napolitano G; Caruso N; Cocchiara E; Accadia L; Perri F; Andriulli A
    Dis Colon Rectum; 2005 Jan; 48(1):57-64; discussion 64-5. PubMed ID: 15690658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of atopy is unrelated to presence of inflammatory bowel disease.
    Troncone R; Merrett TG; Ferguson A
    Clin Allergy; 1988 Mar; 18(2):111-7. PubMed ID: 3365856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.
    Rüthlein J; Ibe M; Burghardt W; Mössner J; Auer IO
    Gut; 1992 Apr; 33(4):507-12. PubMed ID: 1582596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune competence of patients with inflammatory bowel disease.
    Bolton PM; James SL; Newcombe RG; Whitehead RH; Hughes LE
    Gut; 1974 Mar; 15(3):213-9. PubMed ID: 4841278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and humoral response to Kunin antigen (CA) in ulcerative colitis and Crohn's disease.
    Bartnik W; Kałuzewski S
    Arch Immunol Ther Exp (Warsz); 1979; 27(4):531-8. PubMed ID: 518259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
    Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
    J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immunity in Crohn's disease.
    Kraft SC
    Gastroenterology; 1971 Oct; 61(4):545-8. PubMed ID: 4939936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.